Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you realise your usual injection day has shifted by a day or two, you are not alone, and the practical answer is reassuring: a single day's variation in either direction is unlikely to cause problems for most people. Mounjaro (tirzepatide) is a once-weekly subcutaneous injection, and its long half-life gives a reasonable window of flexibility. That said, this is a prescription medicine, and your prescriber or the NHS patient information for tirzepatide should be your first reference for any decision about timing, because the right guidance depends on your individual clinical picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide has a half-life of approximately five days, which means the medicine is clearing your system slowly and steadily between injections. A one-day shift in either direction leaves you well within the therapeutic range for most people. There is a common worry that the slightest deviation will undo weeks of progress or cause a surge in side effects. In practice, that is not how the pharmacology works, and it is worth letting that anxiety go.
The licensed recommendation is to take Mounjaro on the same day each week to keep levels stable and make the routine easy to maintain. But the guidance also acknowledges that life gets in the way. A social event, a travel day, a forgotten pen left at home: these things happen. What matters more is that doses are not taken less than three days apart, because bunching injections too close together raises the likelihood of gastrointestinal side effects without adding benefit. At the other end, the longer a dose is delayed beyond the standard seven-day window, the more the medicine's steady-state levels dip. A brief look at questions our prescribers hear most weeks confirms this is one of the top five.
For broader background on how tirzepatide works as a dual GIP and GLP-1 receptor agonist, the tirzepatide overview covers the mechanism in plain language.
Sometimes the question is less about forgetting and more about planning. You might be heading on holiday on your usual injection day, or a medical appointment clashes with your routine. Taking Mounjaro one day early, so the dose falls six days after the previous one rather than seven, sits comfortably within the flexibility the medicine's pharmacology allows. The gap is still long enough to avoid the side-effect risk that comes with doses taken too close together.
The key is what you do afterwards. Taking it early once is straightforward. Taking it early two or three weeks running gradually compresses your schedule until doses are dangerously close together. So the practical approach is: administer on the early day, then return to your original weekly day for the next injection, accepting that this particular interval will be slightly longer than usual. That single longer gap is not a problem. More detailed guidance on planning an early injection sits on the taking Mounjaro a day early page if you want to read further.
Thinking about whether Mounjaro might be suitable for you in the first place? The weight-loss treatments overview explains eligibility and the options available.
A day's delay is handled the same way in reverse. Take the missed dose as soon as you remember, provided it is no more than four days (approximately 96 hours) after your scheduled day. Once you have taken it, your next injection returns to the original weekly day. The Patient Information Leaflet included with every Mounjaro pen sets out the exact four-day rule clearly, and the MHRA Yellow Card scheme is also where patients can report any unexpected effects they notice around timing changes.
If more than four days have passed since the missed dose, skip it entirely and resume on your next regular injection day. Do not double up. Two doses in quick succession increase the chance of nausea, vomiting and other gastrointestinal effects without any clinical benefit. This is the same principle that applies to taking doses too early: the minimum gap of three days exists precisely to protect you.
Questions about delays stretching further than a day are covered separately on the taking Mounjaro a day late page, and if you have concerns about a gap of several days, the two-day timing guidance may also be relevant context.
Most single-day timing variations are low-stakes and the leaflet guidance is sufficient. There are situations, though, where a direct conversation is the right call. If you are at a higher dose, already managing gastrointestinal side effects, or have an underlying condition that affects how your body processes the medicine, any change in your injection schedule is worth flagging. The same applies if timing shifts are becoming a pattern rather than a one-off.
At nume, every repeat order is clinically reviewed before it is dispensed, not just rubber-stamped. A prescriber reads your notes each time. That means if your schedule has shifted and you want to document it, raising it through our aftercare team is straightforward. You can also find general FAQs about treatment on the nume FAQs page. The clinical team oversees prescribing standards across the service, so there is always a qualified clinician in the loop. If you are not yet a patient and you are reading this while weighing up whether Mounjaro is right for you, the free consultation is the place to start that conversation properly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.